Fat-reduction effects of conjugated linoleic acid (CLA) have been documented in rodents and pigs. Growing lambs were fed three levels of CLA or Megalac (MEG) which was fed to control for energy content. In adipose tissue, the proportions of both CLA isomers increased with CLA supplementation fed but not with Megalac inclusion. A similar dose accumulation with increasing CLA was seen for the trans-10, cis-12 isomer in samples of L. dorsi muscle. However, although the tissues had been enriched with CLA, there was no evidence of a fat reduction in these sheep.
INTRODUCTION
Altering the fatty acid composition and fat:lean ratio of sheep tissues may be benefi cial in terms of human health. Recent research has focused on a component of ruminant fat, conjugated linoleic acid (CLA), which has been implicated with numerous health promoting properties (Belury, 1995) . A fat-reduction effect of CLA has been well documented in mice (Park et al., 1997; West et al., 1998) , rats (Sisk et al., 2001 ) and pigs (Dugan et al., 1997; Ostrowska et al., 1999 Ostrowska et al., , 2003 . More specifi cally Park et al. (1999) provided evidence that the infl uence of CLA on carcass composition is attributed to the trans-10, cis-12 isomer, which has also been linked to a reduction in milk fat content in dairy cows (Baumgard et al., 2001) . However, there is little evidence to suggest dietary supplementation * R.J. Wynn was funded by a BBSRC CASE studentship with Pfi zer and the authors wish to acknowledge J. Craigon (University of Nottingham) for statistical advice with CLA effect tissue composition in growing ruminants. Consequently, we hypothesized that feeding growing lambs a rumen-protected CLA supplement would enrich their tissue CLA content and thus alter their growth and carcass characteristics.
MATERIAL AND METHODS
Thirty-six Charollais x Mule ewe lambs (age 10 wks; average initial liveweight 29.3 kg) were fed three levels of rumen protected CLA (CLA), containing similar levels of the two major CLA isomers (cis-9, trans-11 and trans-10, cis-12) , or Megalac (MEG; Volac Ltd., UK) which was fed to control for energy content at each CLA level. The CLA was protected by a lipid based coating which, using the dual-phase marker technique of Faichney (1975) in sheep fi tted with rumen and duodenal cannulae, was shown to allow 65% of the CLA to reach the duodenum. Megalac is a commercially available rumen protected fat ingredient composed of a combination of natural plant oil (palm fatty acids) and calcium. Animals were randomly allocated to one of 7 treatment groups which were fed to achieve a growth rate of 180 g/d: basal diet (control; n=6), and then basal diet plus 25 g PCLA/kg diet (CLA1; n=5), 50 g PCLA/kg diet (CLA2; n=5), 100 g PCLA/kg diet (CLA3; n=5), 21.7 g MEG/kg diet (MEG1; n=5) 43.3 g MEG/kg diet (MEG2; n=5) and 86.6 g MEG/kg diet (MEG3; n=5). The trial was conducted over a 10-week period. At slaughter, samples of subcutaneous adipose tissue and L. dorsi muscle were taken and frozen at -40 o C. Various carcass parameters were also measured, as shown in Table 1 . Lipid was extracted using a 2:1 chloroform: methanol solution. Prior to GC analysis using a 60m BPX70 column, adipose tissue (subcutaneous, omental and perirenal) was methylated by base methylation and muscle samples by combined base-acid methylation. Data was analysed by ANOVA to determine the effects of amount of fat × type of fat.
RESULTS
In all adipose tissue depots studied, dietary supplementation resulted an amount of fat × type of fat interaction (P<0.02) for CLA content (Table 1 ). The proportions of both cis-9, trans-11 and trans-10, cis-12 CLA accumulated with increasing with CLA inclusion but were not altered with amount of Megalac fed. Although there was no signifi cant effect on CLA cis-9, trans-11 levels, a similar dose accumulation (P<0.001) of trans-10, cis-12 CLA content with CLA supplementation was determined in the L. dorsi muscle. There was however no evidence of any signifi cant alterations in carcass fat or protein levels with dietary CLA supplementation. -9, trans-11 (c-9,t-11) and trans-10, cis-12 (t-10, c-12 ) measured in subcutaneous (sub), omental (om) and perirenal (peri) adipose tissue and L. dorsi muscle (LD) samples
EFFECT OF CLA IN SHEEP

DISCUSSION
The increasing proportions of both cis-9, trans-11 and trans-10, cis-12 CLA in the lambs fed rumen-protected CLA indicates that CLA was incorporated into the tissues. However, there were no signifi cant effects of feeding the protected CLA supplement on any of the carcass parameters measured. This was surprising since several studies have demonstrated that feeding animals CLA at similar levels promotes a decrease in fat content. In the present study, CLA was fed on a body weight basis and, even taking into account the level of rumen protection, the levels were greater than those used by Ostrowska et al. (1999 Ostrowska et al. ( , 2003 and so an effect of CLA was expected. Figure 1 indicates that the lambs in this study actually had more trans-10, cis-12 CLA in their subcutaneous adipose tissue than Ostrowska et al. (2003) reported in their pig study in which a repartitioning effect of CLA on carcass composition was seen.
CONCLUSIONS
Unlike observations in other species, CLA supplementation did not reduce fat deposition in these sheep. The reasons for this are unknown. Figure 1 . Accumulation of trans-10, cis-12 conjugated linoleic acid in subcutaneous adipose tissue of sheep in this study and pigs (Ostrowska et al., 2003) fed diets supplemented with CLA. The grams of t-10, c-12 CLA reaching the duodenum per kg diet takes into account the relative content of CLA isomers in the diets fed and the sheep data takes into account estimated rumen protection
